<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">PP</journal-id><journal-title-group><journal-title>Pharmacology &amp; Pharmacy</journal-title></journal-title-group><issn pub-type="epub">2157-9423</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/pp.2022.138024</article-id><article-id pub-id-type="publisher-id">PP-119371</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject><subject> Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Antibiotic Prescribing Patterns and Prevalence of Surgical Site Infections in Caesarean Section Deliveries at Two Tertiary Hospitals in Lusaka, Zambia
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maisa</surname><given-names>Kasanga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Misheck</surname><given-names>Chileshe</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Steward</surname><given-names>Mudenda</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Raphael</surname><given-names>Mukosha</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maika</surname><given-names>Kasanga</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Victor</surname><given-names>Daka</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tobela</surname><given-names>Mudenda</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maureen</surname><given-names>Chisembele</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>John</surname><given-names>Musuku</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Benjamin</surname><given-names>Bisesa Solochi</given-names></name><xref ref-type="aff" rid="aff10"><sup>10</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jian</surname><given-names>Wu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff9"><addr-line>Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia</addr-line></aff><aff id="aff1"><addr-line>College of Public Health, Zhengzhou University, Zhengzhou, China</addr-line></aff><aff id="aff10"><addr-line>Department of Pathology and Microbiology, University Teaching Hospitals, Lusaka, Zambia</addr-line></aff><aff id="aff8"><addr-line>Department of Obstetrics and Gynaecology, University of Zambia-School of Medicine, Lusaka, Zambia</addr-line></aff><aff id="aff3"><addr-line>Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia</addr-line></aff><aff id="aff7"><addr-line>Department of Pathology, Ndola Teaching Hospital, Ndola, Zambia</addr-line></aff><aff id="aff6"><addr-line>Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia</addr-line></aff><aff id="aff5"><addr-line>Department of Pharmacy, University Teaching Hospitals, Lusaka, Zambia</addr-line></aff><aff id="aff4"><addr-line>Laboratory Department, Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia</addr-line></aff><aff id="aff2"><addr-line>Mary Begg Health Services, Ndola, Zambia</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>08</month><year>2022</year></pub-date><volume>13</volume><issue>08</issue><fpage>313</fpage><lpage>330</lpage><history><date date-type="received"><day>1,</day>	<month>July</month>	<year>2022</year></date><date date-type="rev-recd"><day>21,</day>	<month>August</month>	<year>2022</year>	</date><date date-type="accepted"><day>24,</day>	<month>August</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: A caesarean section (CS) is one of the most frequently performed obstetric surgeries in the world and its use has increased dramatically in recent years. The number of caesarean section cases worldwide has been increasing each year, and the World Health Organization (WHO) reported an excess of 10% - 15% of CS procedures for all births. However, some women experience surgical site infections (SSIs) after undergoing CS delivery. This study investigated the prescribing patterns of antibiotics in CS deliveries and the prevalence of SSIs at two tertiary hospitals in Lusaka, Zambia. 
  Materials and Methods: A retrospective cross-sectional study was conducted from January 2020 to December 2020 at the Women and Newborn University Teaching Hospital (UTH) and the Levy Mwanawasa University Teaching Hospital, in Lusaka, Zambia. 
  Results: Of a total of 838 women who delivered via CS, more than half were aged between 21 and 25 years (n = 461, 55.0%), 56.3% were from low-cost residential areas, and 57% had emergency CS delivery. The prevalence of SSIs was 6.0%, with the level of education (OR 0.377, 95% CI 0.150 - 0.946), type of caesarean section (OR 6.253, 95% CI 2.833 - 13.803), and oral antibiotics post-caesarean (OR 0.218, 95% CI 0.049 - 0.963). The duration of IV antibiotic treatment significantly predicted SSI (p &lt; 0.001), and 99.8% of the women received antibiotic(s). The antibiotic combination of benzylpenicillin, gentamicin, and metronidazole was the most commonly prescribed (n = 39, 146.7%), followed by ceftriaxone (n = 349, 41.6%). 
  Conclusion: This study found that the third-generation cephalosporin (cefotaxime) and triple combination therapy (benzylpenicillin, gentamicin, and metronidazole) were the most frequently prescribed antibiotics before and after CS. The level of education, type of CS, oral antibiotics post-CS, facility, and duration of administering IV antibiotics were all predictors of SSIs.
 
</p></abstract><kwd-group><kwd>Antibiotic Prescribing Patterns</kwd><kwd> Caesarean Section</kwd><kwd> Post-Operative Antibiotics</kwd><kwd> Prophylactic Antibiotics</kwd><kwd> Surgical Site Infections</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>A caesarean section (CS) is a surgical procedure in which incisions are made through a woman’s abdomen and uterus to deliver her baby [<xref ref-type="bibr" rid="scirp.119371-ref1">1</xref>]. It may be necessary if vaginal delivery poses a risk to the mother or baby when there is prolonged labour, foetal distress, or the baby is presenting in an abnormal position [<xref ref-type="bibr" rid="scirp.119371-ref2">2</xref>]. As compared with vaginal delivery, women who have a caesarean section have a five- to ten-fold increased risk of complications associated with infection [<xref ref-type="bibr" rid="scirp.119371-ref3">3</xref>]. In addition, a CS can cause significant complications, disability, or death, particularly in settings that lack the facilities to conduct safe surgeries or treat potential complications [<xref ref-type="bibr" rid="scirp.119371-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref5">5</xref>].</p><p>A CS delivery is one of the most common operative procedures performed in Sub-Saharan Africa (SSA), accounting for as much as 80% of the surgical workload [<xref ref-type="bibr" rid="scirp.119371-ref6">6</xref>]. In contrast to CS deliveries performed in high-income countries, those performed in SSA are primarily emergency operations and are accompanied by high morbidity and mortality rates [<xref ref-type="bibr" rid="scirp.119371-ref6">6</xref>]. This operation is the most important known variable associated with an increased probability of postpartum bacterial infection as compared with vaginal birth, with reported rates of infection ranging from 1% to 25%, about 5 to 20 times higher than that of vaginal delivery [<xref ref-type="bibr" rid="scirp.119371-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref7">7</xref>].</p><p>Infectious complications following a caesarean section delivery include fever, wound infection, endometritis, and urinary tract infection. Serious complications include pelvic abscess, bacteraemia, septic shock, and septic pelvic vein thrombophlebitis that can sometimes lead to maternal mortality [<xref ref-type="bibr" rid="scirp.119371-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref10">10</xref>]. Preventive measures have been suggested to avoid post-caesarean infection including proper preparation of an incision site which can reduce the bacterial population to a minimal level [<xref ref-type="bibr" rid="scirp.119371-ref9">9</xref>].</p><p>Antimicrobials are commonly prescribed in obstetrics and gynaecology prophylactically for pre- and postoperative procedures [<xref ref-type="bibr" rid="scirp.119371-ref11">11</xref>]. First-generation cephalosporins including ceftriaxone, cefotaxime, and cefazolin have been reported to be the most commonly used for prophylaxis [<xref ref-type="bibr" rid="scirp.119371-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref14">14</xref>]. Prophylactic antibiotics reduce the incidence of SSIs and evidence-based guidelines recommend the use of antibiotics before an incision [<xref ref-type="bibr" rid="scirp.119371-ref15">15</xref>]. In recent times, despite the importance of antibiotic use for post-caesarean infection prevention, the injudicious and prolonged administration of antibiotics has led to a surge in the emergence of resistant strains of microorganisms [<xref ref-type="bibr" rid="scirp.119371-ref16">16</xref>]. Without newer antibiotics being developed over the next few years, the optimum use of antibiotics remains to be a challenge for many countries and hospitals [<xref ref-type="bibr" rid="scirp.119371-ref17">17</xref>].</p><p>The antibiotic prescribing patterns in a maternity ward are influenced by several factors such as premature rupture of the membrane which predisposes a patient to chorioamnionitis, endometritis, and neonatal infections [<xref ref-type="bibr" rid="scirp.119371-ref18">18</xref>], the age of the patient, obesity, gestational diabetes mellitus, and a prolonged trial of labour before CS delivery [<xref ref-type="bibr" rid="scirp.119371-ref19">19</xref>].</p><p>Furthermore, irrational use of antibiotics has been identified as one of the factors contributing to the emergence of antimicrobial resistance and, as such, negatively impacting both treatment and prophylaxis [<xref ref-type="bibr" rid="scirp.119371-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref21">21</xref>]. Therefore, it is important to assess the antibiotic prescribing patterns in labour/maternity wards and their prophylaxis effectiveness in preventing post-CS infection.</p><p>In this study, we investigated the prescribing patterns of antibiotics before and after CS deliveries and the occurrence of SSIs at two tertiary hospitals in Lusaka, Zambia.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Study Site</title><p>This study was a retrospective hospital-based cross-sectional study conducted using medical charts for 838 patients who underwent CS delivery from January 2020 to August 2020. The study was performed at the UTH and the LMUTH in Lusaka. The UTH and LMUTH are the leading institutions in maternal, reproductive health, and newborn care in Zambia. They act as referral hospitals for surrounding districts and are centres of excellence in research and training.</p></sec><sec id="s2_2"><title>2.2. Data Collection</title><p>The data were collected retrospectively from labour room medical records using a predefined data collection checklist that was adapted from the World Health Organization (WHO) tools for investigating drug use in healthcare facilities (Appendix). The data included patient demographics (age, religion, marital status, level of education, occupation, and place of residence), date of admission, indication for caesarean section, date and type of caesarean section, medications prescribed, type of wound infection, and length of hospital stay. The wound infection results were collected from the microbiology laboratory system. The data were cleaned and examined for completeness during collection, and incomplete patient medical records were excluded.</p></sec><sec id="s2_3"><title>2.3. Inclusion Criteria</title><p>This study included all medical charts that had complete information including age, indication for caesarean section, and demographic factors. The charts of all women who underwent CS delivery (elective or non-elective) during the study period and also had other complications that warranted the use of antibiotics apart from prophylaxis were included in the study.</p></sec><sec id="s2_4"><title>2.4. Exclusion Criteria</title><p>The charts of all women who underwent CS delivery but with incomplete information such as age, indication for caesarean section, and other demographic factors were not included in the study. The charts of these women who underwent caesarean section and also had other complications that warranted the use of antibiotics apart from prophylaxis were not included in the study.</p></sec><sec id="s2_5"><title>2.5. Data Analysis</title><p>The collected data were entered into Microsoft excel and were checked for completeness, inconsistencies, and missing values, and then coded. Data were analysed using SPSS version 21.0. Descriptive statistics were used to determine frequencies and percentages to describe the study population with sociodemographic and other relevant variables. A chi-square test of association was performed to determine the distribution of antibiotic prescribing patterns, by the facility. Backward stepwise binary logistic regression was performed to determine the factors that would independently predict SSI post caesarean section. A p-value ≤0.05, with a 95% confidence interval, was considered to be statistically significant.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Demographic and Clinical Information of the Participants</title><p>We reviewed a total of 838 medical files of women who delivered through CS. More than half (55%) of the women who had CS deliveries were aged between 21 and 25 years, and slightly over one-third (38.9%) of these women had attained only a secondary education level. The distribution of respondents by site was similar, with 417 (49.8%) from the UTH and 421 (50.2%) from the LMUTH. In addition, most of the women, 478/838 (57.0%) had undergone an emergency CS and 50 (6.0%) experienced SSIs (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Factors that Independently Predict Surgical Infection Post Caesarean Section Surgery</title><p>A backward stepwise binary logistic regression was performed to determine the factors that would independently predict the existence of SSI post-CS surgery.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Sociodemographic and clinical information of the women who delivered through caesarean section</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Factors</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle"  rowspan="5"  >Age</td><td align="center" valign="middle" >15 - 20 Years</td><td align="center" valign="middle" >145</td><td align="center" valign="middle" >17.3</td></tr><tr><td align="center" valign="middle" >21 - 25 Years</td><td align="center" valign="middle" >461</td><td align="center" valign="middle" >55.0</td></tr><tr><td align="center" valign="middle" >26 - 30 Years</td><td align="center" valign="middle" >208</td><td align="center" valign="middle" >24.8</td></tr><tr><td align="center" valign="middle" >31 - 40 Years</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >2.9</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >838</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Level of education</td><td align="center" valign="middle" >Primary Secondary Tertiary Total</td><td align="center" valign="middle" >210 326 302 838</td><td align="center" valign="middle" >25.1 38.9 36.0 100</td></tr><tr><td align="center" valign="middle" >Residential area</td><td align="center" valign="middle" >Low cost Medium High cost Total</td><td align="center" valign="middle" >472 266 100 838</td><td align="center" valign="middle" >56.3 31.7 11.9 100</td></tr><tr><td align="center" valign="middle" >Marital status</td><td align="center" valign="middle" >Single Married Divorced Total</td><td align="center" valign="middle" >511 323 4 838</td><td align="center" valign="middle" >61.0 38.5 0.5 100</td></tr><tr><td align="center" valign="middle" >Facility</td><td align="center" valign="middle" >UTH LMUTH Total</td><td align="center" valign="middle" >417 421 838</td><td align="center" valign="middle" >49.8 50.25 100</td></tr><tr><td align="center" valign="middle" >Type of caesarean section</td><td align="center" valign="middle" >Elective Emergency Total</td><td align="center" valign="middle" >360 478 838</td><td align="center" valign="middle" >43.0 57.0 100</td></tr><tr><td align="center" valign="middle" >Prevalence of SSIs</td><td align="center" valign="middle" >Yes No</td><td align="center" valign="middle" >50 788</td><td align="center" valign="middle" >6 94</td></tr></tbody></table></table-wrap><p>Key: SSIs = surgical site infections.</p><p>The factors that were found to significantly contribute to the model, and hence included in the analysis, were level of education, type of caesarean section, post-CS oral antibiotics being prescribed, facility at which the CS was performed, and duration of IV antibiotics treatment. Women who had attended secondary school were 2.653 times more likely not to have surgical site infection as compared with those who only attended up to primary school (OR = 2.653, 95% CI 1.057 - 6.667, p = 0.038). Women who had elective CS delivery were 6.253 likely of having no surgical site infection as compared with emergency CS delivery (OR = 6.253, 955% CI 2.833 - 13.803, p &lt; 0. 001). In addition, women who had CS delivery at the UTH were 0.059 times less likely to have no surgical site infection as compared with those who had CS delivery at the LMUTH (OR = 0.059, 95% CI 0.020 - 0.173, p &lt; 0.001). Having a longer duration of post-CS IV antibiotic treatment resulted in a greater chance of having no surgical site infection as compared with antibiotic treatment for a duration of fewer than 7 days; OR = 18.044, 95% CI 6.607 - 49.279, p &lt; 0.001 and OR = 6.868, 95% CI 2.823 - 16.710, p &lt; 0.001, concerning 8 - 15 days and 16 - 22 days of IV antibiotic treatment, respectively, as shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p></sec><sec id="s3_3"><title>3.3. Pre-Caesarean Section Antibiotic Prescribing Patterns by Facility</title><p>Almost every woman (n = 836, 99.8%) who had CS delivery received an antibiotic before the CS operation. Overall, the triple therapy of X-pen, gentamicin, and metronidazole was the most commonly prescribed antibiotic combination (n = 391, 46.7%), followed by ceftriaxone (n = 349, 41.6%). The other antibiotics and their prescription patterns are shown in <xref ref-type="table" rid="table3">Table 3</xref>. The most commonly prescribed pre-CS antibiotic prescribed at the UTH was ceftriaxone (n = 290, 34.6%), while at the LMUTH, it was a combination of X-pen, gentamicin, and metronidazole (n = 339, 40.5%), as shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Factors independently associated with surgical site infection post-CS delivery</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Odds Ratio</th><th align="center" valign="middle" >95% Confidence Interval</th><th align="center" valign="middle" >(p-Value)</th></tr></thead><tr><td align="center" valign="middle" >Level of education</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >0.377</td><td align="center" valign="middle" >0.150 - 0.946</td><td align="center" valign="middle" >0.038</td></tr><tr><td align="center" valign="middle" >Tertiary</td><td align="center" valign="middle" >0.677</td><td align="center" valign="middle" >0.249 - 1.610</td><td align="center" valign="middle" >0.338</td></tr><tr><td align="center" valign="middle" >Type of caesarean section</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Emergency</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Elective</td><td align="center" valign="middle" >6.253</td><td align="center" valign="middle" >2.833 - 13.803</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Post CS oral antibiotics prescribed</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >0.218</td><td align="center" valign="middle" >0.049 - 0.963</td><td align="center" valign="middle" >0.045*</td></tr><tr><td align="center" valign="middle" >The facility at which CS was performed</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >LMUTH</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >UTH</td><td align="center" valign="middle" >0.059</td><td align="center" valign="middle" >0.020 - 0.173</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Duration of IV antibiotics</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;7 days</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >8 - 15 days</td><td align="center" valign="middle" >18.044</td><td align="center" valign="middle" >6.607 - 49.279</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >16 - 22 days</td><td align="center" valign="middle" >6.868</td><td align="center" valign="middle" >2.823 - 16.710</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>OR, odds ratio; UTH, University Teaching Hospital; LMUTH, Levy Mwanawasa University Teaching Hospital; CS, caesarean section.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Pre-caesarean section antibiotic prescribing patterns in study sites</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Factor</th><th align="center" valign="middle"  colspan="2"  >Facility</th><th align="center" valign="middle"  rowspan="2"  >Total percent</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >UTH n (%)</td><td align="center" valign="middle" >LMUTH n (%)</td></tr><tr><td align="center" valign="middle" >Pre-CS antibiotics given Yes No Total</td><td align="center" valign="middle" >415 (49.5) 2 (0.2)</td><td align="center" valign="middle" >421 (50.2) 0 (0.0)</td><td align="center" valign="middle" >836 (99.8) 2 (0.2) 838 (100)</td><td align="center" valign="middle" >0.247</td></tr><tr><td align="center" valign="middle" >Antibiotics prescribed Cefotaxime Ceftriaxone</td><td align="center" valign="middle" >11 (1.3) 290 (34.6)</td><td align="center" valign="middle" >3 (0.4) 59 (7.0)</td><td align="center" valign="middle" >14 (1.7) 349 (41.6)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >X-pen, gentamicin, and Metronidazole Metronidazole</td><td align="center" valign="middle" >52 (6.2) 14 (1.7)</td><td align="center" valign="middle" >339 (40.5) 0 (0.0)</td><td align="center" valign="middle" >391 (46.7) 14 (1.7)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Ceftriaxone, and metronidazole Metronidazole, and erythromycin</td><td align="center" valign="middle" >13 (1.6) 1 (0.1)</td><td align="center" valign="middle" >4 (0.5) 0 (0.0)</td><td align="center" valign="middle" >17 (2.0) 1 (0.1)</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Cefuroxime Sulfamethoxazole-trimethoprim</td><td align="center" valign="middle" >23 (2.7) 1 (0.1)</td><td align="center" valign="middle" >10 (1.2) 1 (0.1)</td><td align="center" valign="middle" >33 (3.9) 2 (0.2)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gentamicin and metronidazole Sulfamethoxazole-trimethoprim</td><td align="center" valign="middle" >2 (0.2) 2 (0.2)</td><td align="center" valign="middle" >0 (0.0) 0 (0.0)</td><td align="center" valign="middle" >2 (0.2) 2 (0.2)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Amoxicillin and metronidazole Benzylpenicillin (X-pen)</td><td align="center" valign="middle" >1 (0.1) 0 (0.0)</td><td align="center" valign="middle" >0 (0.0) 1 (0.1)</td><td align="center" valign="middle" >1 (0.1) 1 (0.1)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >X-pen, gentamicin, and ceftriaxone N/A (antibiotics not prescribed)</td><td align="center" valign="middle" >5 (0.6) 2 (0.2)</td><td align="center" valign="middle" >4 (0.5) 0 (0.0)</td><td align="center" valign="middle" >9 (1.1) 2 (0.2)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >838 (100)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>On the one hand, the timing of prophylaxis was reported to be adequate in 99.8% of the cases of pre-CS antibiotic treatment, but this did not seem to affect SSI prevalence. On the other hand, post-operative antibiotic administration was significantly lower in the post-CS treatment (p &lt; 0.005).</p></sec><sec id="s3_4"><title>3.4. Post-Caesarean Section IV Antibiotic Prescribing Patterns by Facility</title><p>Among the 838 women who underwent CS surgery, 812 women (812/838), representing 96.9% of all the women involved in this study, received post-caesarean section intravenous (IV) antibiotics and the majority of them received them for less than 7 days, 396/838 (47.3%). Overall, the X-pen, gentamicin, and metronidazole combination therapy was a highly prescribed antibiotic combination at both facilities, 555/838 (66.2%), followed by ceftriaxone, 166/838 (19.8%), the majority of which was prescribed at UTH, as indicated in <xref ref-type="table" rid="table4">Table 4</xref>.</p></sec><sec id="s3_5"><title>3.5. Post-Caesarean Section Oral Antibiotic Prescribing Patterns by Facility</title><p>Among the 838 women who delivered through CS, 744/838 (88.7%) received post-CS oral antibiotics. Three-quarters of all the prescribed oral antibiotics</p><p>were a combination of amoxicillin and metronidazole, 631/838 (75.3%), and by</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Post-caesarean section IV antibiotic prescribing patterns</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Factor</th><th align="center" valign="middle"  colspan="2"  >Facility</th><th align="center" valign="middle"  rowspan="2"  >Total (%)</th><th align="center" valign="middle"  rowspan="2"  >P-value</th></tr></thead><tr><td align="center" valign="middle" >UTH n(%)</td><td align="center" valign="middle" >LMUTH n (%)</td></tr><tr><td align="center" valign="middle" >Post-CS IV antibiotics given Yes No Total</td><td align="center" valign="middle" >397 (47.4) 20 (2.4)</td><td align="center" valign="middle" >415 (49.5) 6 (0.7)</td><td align="center" valign="middle" >812 (96.9) 26 (3.1) 838 (100.0)</td><td align="center" valign="middle" >0.005*</td></tr><tr><td align="center" valign="middle" >Antibiotics prescribed Ceftriaxone X-pen, gentamicin, and metronidazole Cefotaxime Ceftriaxone and metronidazole Metronidazole Cefuroxime Gentamicin Metronidazole and cefuroxime Gentamicin, metronidazole, and cefuroxime N/A (Antibiotics not prescribed) Total</td><td align="center" valign="middle" >152 (18.1) 171 (20.4) 9 (1.1) 44 (5.3) 8 (1.0) 10 (1.2) 1 (0.1) 1 (0.1) 1 (0.1) 20 (2.4)</td><td align="center" valign="middle" >14 (1.7) 384 (45.8) 0 (0.0) 17 (2.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 6 (0.7)</td><td align="center" valign="middle" >166 (19.8) 555 (66.2) 9 (1.1) 61 (7.3) 8 (1.0) 10 (1.2) 1 (0.1) 1 (0.1) 1 (0.1) 26 (3.1) 838 (100.0)</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Duration of IV antibiotic treatment &lt;7 days 8 - 15 days 16 - 22 days None (never received IV Antibiotics) Total</td><td align="center" valign="middle" >187 (22.3) 179 (21.4) 31 (3.7) 20 (2.4)</td><td align="center" valign="middle" >209 (24.9) 199 (23.7) 7 (0.8) 6 (0.7)</td><td align="center" valign="middle" >396 (47.3) 378 (45.1) 38 (4.5) 26 (3.1) 838 (100.0)</td><td align="center" valign="middle" >&lt;0.001*</td></tr></tbody></table></table-wrap><p>facility, they were the most prescribed oral antibiotic combination as shown in <xref ref-type="table" rid="table5">Table 5</xref>.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The rate of CS delivery is constantly growing due to both justifiable and non-justifiable medical and nonmedical reasons [<xref ref-type="bibr" rid="scirp.119371-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref23">23</xref>]. Several notable advancements have been achieved in surgery including refinement of infection control measures such as improvement of surgical techniques, barrier nursing, and antimicrobial prophylaxis. Despite these positive scores, SSIs continue to be a major cause of maternal morbidity and prolonged hospital stay [<xref ref-type="bibr" rid="scirp.119371-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref25">25</xref>]. Reports have shown that women who delivered via CS were 5 to 20 times more likely to get infected than women who have had a vaginal delivery, and regular use of antibiotics in women who deliver through CS reduces the risk of infection [<xref ref-type="bibr" rid="scirp.119371-ref26">26</xref>].</p><p>Caesarean section (CS) post-operative infections may be caused by bacteria such as Staphylococcus epidermis, Staphylococcus aureus Group B streptococci, or Enterococcus species. The WHO has also recommended routine prophylactic antibiotics for women undergoing elective and emergency CS delivery. In the current study, it was found that up to 99.6% of women who underwent CS</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Post-caesarean section oral antibiotic prescribing patterns</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Factor</th><th align="center" valign="middle"  colspan="2"  >Facility</th><th align="center" valign="middle"  rowspan="2"  >Total percent</th><th align="center" valign="middle"  rowspan="2"  >P-value</th></tr></thead><tr><td align="center" valign="middle" >UTH n (%)</td><td align="center" valign="middle" >LMUTH n (%)</td></tr><tr><td align="center" valign="middle" >Post-CS Oral antibiotics given Yes No Total</td><td align="center" valign="middle" >339 (40.4) 78 (9.3)</td><td align="center" valign="middle" >405 (48.3) 16 (1.9)</td><td align="center" valign="middle" >744 (88.7) 94 (11.2) 838 (100)</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Antibiotics prescribed Ceftriaxone Cefuroxime Amoxicillin and metronidazole Metronidazole Ceftriaxone and metronidazole Ciprofloxacin and doxycycline Benzylpenicillin (Xpen) &amp; gentamicin Amoxicillin Xpen, gentamicin, and ceftriaxone Cefuroxime and clotrimazole Metronidazole and gentamicin Erythromycin and metronidazole Xpen, gentamicin, and Amoxicillin Metronidazole &amp; Cefuroxime Cefuroxime &amp; Erythromycin Sulfamethoxazole-trimethoprim Cefuroxime and Amoxicillin Cephalexin and metronidazole Cefotaxime and metronidazole N/A (no antibiotics were given) Total</td><td align="center" valign="middle" >13 (1.6) 10 (1.2) 259 (30.9) 9 (1.1) 19 (2.3) 1 (0.1) 3 (0.4) 4 (0.5) 10 (1.2) 2 (0.2) 2 (0.2) 1 (0.1) 2 (0.2) 2 (0.2) 1 (0.1) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 78 (9.3)</td><td align="center" valign="middle" >2 (0.2) 1 (0.1) 372 (44.4) 6 (0.7) 2 (0.2) 0 (0.0) 0 (0.0) 1 (0.1) 2 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 11 (1.3) 1 (0.1) 3 (0.4) 4 (0.5) 16 (1.9)</td><td align="center" valign="middle" >15 (1.8) 11 (1.3) 631 (75.3) 15 (1.8) 21 (2.5) 1 (0.1) 3 (0.4) 5 (0.6) 12 (1.4) 2 (0.2) 2 (0.2) 1 (0.1) 2 (0.2) 2 (0.2) 1 (0.1) 12 (1.4) 1 (0.1) 3 (0.4) 4 (0.5) 94 (11.2) 838 (100.0)</td><td align="center" valign="middle" >&lt;0.001*</td></tr></tbody></table></table-wrap><p>On the one hand, the timing of prophylaxis was reported to be adequate in 96.9% of the cases in the post-CS treatment, but this did not seem to affect SSI prevalence. On the other hand, postoperative oral antibiotic administration was significantly lower in the post-CS treatment (p &lt; 0.001).</p><p>delivery were prescribed antibiotics in line with the WHO recommendation. According to the WHO, cephalosporins are the first line of antibiotic treatment prescribed for CS patients, and then penicillins [<xref ref-type="bibr" rid="scirp.119371-ref27">27</xref>].</p><p>In the current study, it was noted that the majority of women who delivered through CS were in the age group between 21 and 25 years and above, which was in agreement with several similar studies [<xref ref-type="bibr" rid="scirp.119371-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref30">30</xref>]. In our study, the most commonly prescribed antibiotics were the combination of benzylpenicillin, gentamicin and metronidazole or cefotaxime. This is in agreement with another study [<xref ref-type="bibr" rid="scirp.119371-ref29">29</xref>] and corroborates the WHO guidelines [<xref ref-type="bibr" rid="scirp.119371-ref27">27</xref>].</p><p>Our study demonstrated that 56% of women who underwent CS delivery were from low-cost residential areas, similar to other studies [<xref ref-type="bibr" rid="scirp.119371-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref31">31</xref>]. It was also determined that all the patients who had CS delivery received perioperative antibiotic prophylaxis and anaesthetic. Antibiotics are very important both before and after skin incisions to prevent skin and SSIs. A similar study also showed that administering antibiotic prophylaxis before skin incision compared with after cord clamping significantly reduced the incidence of maternal infection [<xref ref-type="bibr" rid="scirp.119371-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref32">32</xref>].</p><p>This study found a 6.0% prevalence of SSIs. This was in line with earlier findings from Egypt (5.3%) [<xref ref-type="bibr" rid="scirp.119371-ref33">33</xref>], Ankara (6.2%) [<xref ref-type="bibr" rid="scirp.119371-ref34">34</xref>], Pennsylvania (6.5%) [<xref ref-type="bibr" rid="scirp.119371-ref34">34</xref>], and SSA (7.3%) [<xref ref-type="bibr" rid="scirp.119371-ref35">35</xref>]. Conversely, the prevalence of SSIs found in our study was lower than what was found in similar studies with a prevalence of 10.9% in Tanzania [<xref ref-type="bibr" rid="scirp.119371-ref36">36</xref>], 11% in Ethiopia [<xref ref-type="bibr" rid="scirp.119371-ref37">37</xref>], 16.2% in Nigeria [<xref ref-type="bibr" rid="scirp.119371-ref38">38</xref>], 12.6% in Nepal [<xref ref-type="bibr" rid="scirp.119371-ref39">39</xref>] and 24.3% in Pakistan [<xref ref-type="bibr" rid="scirp.119371-ref40">40</xref>]. These results are not consistent with another study [<xref ref-type="bibr" rid="scirp.119371-ref41">41</xref>] which found that 7.5% of the CS deliveries had SSIs. This is presumably due to the long duration of prophylaxis [<xref ref-type="bibr" rid="scirp.119371-ref41">41</xref>].</p><p>Some other studies have indicated that emergency CS deliveries have been linked to SSIs, due to highly urgent operations with fewer concerns about sterility and the absence of prophylactic antibiotics administered on time [<xref ref-type="bibr" rid="scirp.119371-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref43">43</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref44">44</xref>]. This is similar to what was found in our study, in which we demonstrated a greater association between elective CS delivery and no surgical site infections as compared with emergency CS deliveries. This was in agreement with what has been previously reported by other studies which indicate that elective CS delivery provides enough time for the initiation of prophylactic antibiotic therapy as well as ensures a sterile environment in which the operation is conducted and has shown to have a protective effect against developing SSIs [<xref ref-type="bibr" rid="scirp.119371-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref43">43</xref>]. Surgical site infections are the most frequent health-acquired infection (HAI) in Sub-Saharan Africa [<xref ref-type="bibr" rid="scirp.119371-ref45">45</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref46">46</xref>]. Compared to elective cases, emergency CS is associated with a higher incidence of SSI (25.2%) versus (7.6%) [<xref ref-type="bibr" rid="scirp.119371-ref47">47</xref>].</p><p>Surgical site infections (SSIs) complicate up to 15% of all CS deliveries [<xref ref-type="bibr" rid="scirp.119371-ref48">48</xref>]. These infections are associated with significant morbidity and they also increase the financial burden of new mothers, their families, and the nation as a whole due to antibiotics that are prescribed for both prophylaxis and treatment, as well as prolonged hospital stays [<xref ref-type="bibr" rid="scirp.119371-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref45">45</xref>]. Gentilotti and colleagues showed that SSI prevalence was 17% post-operation [<xref ref-type="bibr" rid="scirp.119371-ref42">42</xref>]. However, our study found a lower prevalence of SSIs, and this could be due to frequent use of prophylactic antibiotics before skin incision, as shown in our results in which almost every woman took an antibiotic before CS surgery.</p><p>This study shows a high level of antibiotic prescription for women among physicians and a lack of understanding, especially regarding the use of third-generation cephalosporins. High levels of antibiotics prescribed to women undergoing CS delivery indicate that antibiotics are prescribed for prophylactic purposes. The prophylactic use of antibiotics during vaginal deliveries in the study setting is not well understood by most physicians [<xref ref-type="bibr" rid="scirp.119371-ref28">28</xref>].</p><p>Furthermore, irrational use of antibiotics has been identified as one of the factors contributing to the emergence of antimicrobial resistance and, as such, this would negatively impact both treatment and prophylaxis [<xref ref-type="bibr" rid="scirp.119371-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref49">49</xref>]. The surgical site infection prevalence was found to be 6.0% among the women who underwent CS deliveries. Most of the women were given IV antibiotic treatment, which was similar to the reports of other studies noting that for operations lasting four hours or less, one antibiotic dose is usually sufficient. In a prolonged delivery of greater than four hours, a further antibiotic dose may be required to maintain the concentration, particularly if the antibiotic has a short half-life [<xref ref-type="bibr" rid="scirp.119371-ref29">29</xref>]. The prescribed antibiotic should be provided in an adequate dose based on a patient’s body weight, adjusted dosing weight, or body mass index. The administration should be repeated intra-operatively if an operation is still in progress 2 half-lives after the first dose, to ensure adequate antimicrobial levels until wound closure. More studies should be conducted to identify the reasons for the differences. Therefore, it is recommended that physicians observe proper pre- and postoperative antibiotic prophylaxis and reduce the difference in antibiotic selection according to the guidelines.</p><p>The provision of peripheral prophylactic antibiotics for CS delivery is more effective in preventing infection in the surgical area. As explained in a study by Sway et al. (2019), a group taking antibiotics had a higher rate of postoperative infection (9.3%). They argued that the administration of immune antibiotics was the main reason for the decline in infection rates and that the data provided strong evidence that many infectious diseases found in the study population were treated with antibiotics before surgery (i.e. [<xref ref-type="bibr" rid="scirp.119371-ref6">6</xref>]). The use of antibiotic prophylaxis was reduced [<xref ref-type="bibr" rid="scirp.119371-ref6">6</xref>]. However, in this study, there were combinations of benzylpenicillin, gentamicin, and metronidazole, as well as ceftriaxone, or ceftriaxone, and metronidazole and more than one antibiotic class, including amoxicillin and metronidazole [<xref ref-type="bibr" rid="scirp.119371-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref50">50</xref>], demonstrating the effectiveness of the combination of cephalexin and oral metronidazole after delivery in reducing the risk of infection in the surgical field, followed by the administration of standard preoperative prophylactic antibiotics. Subsequently, it is critical to be cautious and watchful when using antibiotics to prevent the development of antimicrobial resistance (AMR) [<xref ref-type="bibr" rid="scirp.119371-ref51">51</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref52">52</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref53">53</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref54">54</xref>]. Additionally, prescribers should ensure that they adhere to the local, national, and international antibiotic prescribing guidelines that promote the rational use of antibiotics and antimicrobial stewardship [<xref ref-type="bibr" rid="scirp.119371-ref55">55</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref56">56</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref57">57</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref58">58</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref59">59</xref>] [<xref ref-type="bibr" rid="scirp.119371-ref60">60</xref>].</p><p>The limitation of this study was that it omitted some variables related to laboratory testing, body mass index (BMI), the main causes of surgical site infections, and service-related factors because the study was conducted using chart reviews. In addition, it did not evaluate the quality of health care, which can be useful for mothers with SSIs after CS delivery. Although we have taken appropriate measures to minimize misclassification, secondary data can lead to the misclassification of study participants. In addition, this study did not check the status of control groups who did not visit the respective hospitals for follow-up care. However, post-release surveillance is essential to address these groups. Recommended antibiotics in combination with cefotaxime, metronidazole, and gentamicin are effective in patients who are hospitalized and discharged within 3 days. Regular educational interventions are needed to improve physician prescribing practices at different levels, which may further promote the rational use of antibiotics.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, our study revealed that third-generation cephalosporin (cefotaxime) and triple combination therapy (benzylpenicillin, gentamicin, and metronidazole) were the most frequently prescribed antibiotics for both pre-and postoperative treatments. There was a lower rate of surgical site infection found in our study which could have been attributed to the prescribed antibiotics before and after CS deliveries. There is a need for continued professional education on the rational prescribing of antibiotics among prescribers.</p></sec><sec id="s6"><title>Author Contributions</title><p>Conceptualization, M.K. (Maisa Kasanga) and S.M.; methodology, M.K. (Maisa Kasanga)., S.M., M.C., and J.W.; analysis, M.K. (Maisa Kasanga)., R.M., and M.C. investigation, M.K. (Maisa Kasanga), J.W., and M.K. (Maika Kasanga); resources, M.K. (Maisa Kasanga) and M.K. (Maika Kasanga); writing—original draft preparation, M.K. (Maisa Kasanga); writing—review and editing M.K. (Maisa Kasanga), M.C., J.W., M.K. (Maika Kasanga) V.D., T.M., and S.M.; supervision, J.W., M.C., and S.M.; project administration, J.W. and M.K. (Maisa Kasanga). All authors have read and agreed to the published version of the manuscript.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We are grateful to the members of staff from the Women and New-born University Teaching Hospital (UTH) and the Levy Mwanawasa University Teaching Hospital labour ward.</p></sec><sec id="s8"><title>Funding</title><p>This study did not receive any external funding. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.</p></sec><sec id="s9"><title>Institutional Review Board Statement</title><p>This study was approved by the University of Zambia Biomedical Ethics Committee (UNZABREC), Federal Assurance #00000338, Protocol #975-2020.</p></sec><sec id="s10"><title>Data Availability Statement</title><p>The datasets used during the current study are available from the corresponding author on rational request.</p></sec><sec id="s11"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></sec><sec id="s12"><title>Cite this paper</title><p>Kasanga, M., Chileshe, M., Mudenda, S., Mukosha, R., Kasanga, M., Daka, V., Mudenda, T., Chisembele, M., Musuku, J., Solochi, B.B. and Wu, J. (2022) Antibiotic Prescribing Patterns and Prevalence of Surgical Site Infections in Caesarean Section Deliveries at Two Tertiary Hospitals in Lusaka, Zambia. Pharmacology &amp; Pharmacy, 13, 313-330. https://doi.org/10.4236/pp.2022.138024</p></sec><sec id="s13"><title>Appendix</title><p>Data collection checklist</p><p>This checklist indicates the variables that will be collected from the medical files and charts of women who underwent C-sections.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.119371-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Kawakita, T. and Landy, H.J. (2017) Surgical Site Infections after Cesarean Delivery: Epidemiology, Prevention and Treatment. Maternal Health, Neonatology and Perinatology, 3, Article No. 12. https://doi.org/10.1186/s40748-017-0051-3</mixed-citation></ref><ref id="scirp.119371-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Assawapalanggool, S., Kasatpibal, N., Sirichotiyakul, S., Arora, R., Suntornlimsiri, W. and Apisarnthanarak, A. (2018) The Efficacy of Ampicillin Compared with Ceftriaxone on Preventing Cesarean Surgical Site Infections: An Observational Prospective Cohort Study. Antimicrobial Resistance and Infection Control, 7, Article No. 13. https://doi.org/10.1186/s13756-018-0304-6</mixed-citation></ref><ref id="scirp.119371-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">La Rosa, M., Omere, C., Redfern, T., Abdelwahab, M., Spencer, N., Villarreal, J., et al. (2020) The Impact of Low-Dose Versus High-Dose Antibiotic Prophylaxis Regimens on Surgical Site Infection Rates after Cesarean Delivery. Archives of Gynecology and Obstetrics, 301, 69-73. https://doi.org/10.1007/s00404-019-05370-y</mixed-citation></ref><ref id="scirp.119371-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Gelaw, K.A., Aweke, A.M., Astawesegn, F.H., Demissie, B.W. and Zeleke, L.B. (2017) Surgical Site Infection and Its Associated Factors Following Cesarean Section: A Cross-Sectional Study from a Public Hospital in Ethiopia. Patient Safety in Surgery, 11, Article No. 18. https://doi.org/10.1186/s13037-017-0131-3</mixed-citation></ref><ref id="scirp.119371-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Caughey, A.B., Wood, S.L., Macones, G.A., Wrench, I.J., Huang, J., Norman, M., et al. (2018) Guidelines for Intraoperative Care in Cesarean Delivery: Enhanced Recovery after Surgery Society Recommendations (Part 2). American Journal of Obstetrics &amp; Gynecology, 219, 533-544. https://doi.org/10.1016/j.ajog.2018.08.006</mixed-citation></ref><ref id="scirp.119371-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sway, A., Nthumba, P., Solomkin, J., Tarchini, G., Gibbs, R., Ren, Y., et al. (2019) Burden of Surgical Site Infection Following Cesarean Section in Sub-Saharan Africa: A Narrative Review. International Journal of Women’s Health, 11, 309-318.  
https://doi.org/10.2147/IJWH.S182362</mixed-citation></ref><ref id="scirp.119371-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Sway, A., Wanyoro, A., Nthumba, P., Aiken, A., Ching, P., Maruta, A., et al. (2020) Prospective Cohort Study on Timing of Antimicrobial Prophylaxis for Post-Cesarean Surgical Site Infections. Surgical Infections, 21, 552-557.  
https://doi.org/10.1089/sur.2018.226</mixed-citation></ref><ref id="scirp.119371-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Jasim, H.H., Sulaiman, S.A.S., Khan, A.H., Dawood, O.T., Abdulameer, A.H. and Usha, R. (2017) Incidence and Risk Factors of Surgical Site Infection among Patients Undergoing Cesarean Section. BMC Infectious Diseases, 9, Article No. 752.  
https://doi.org/10.1177/1179559X17725273</mixed-citation></ref><ref id="scirp.119371-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Abdallah, A. and Sayed, R. (2018) Risk Factors of Surgical Site Infection of Cesarean Section and Role of Skin Cleansing and Prophylactic Antibiotic. International Journal of Reproductive Medicine &amp; Gynecology, 4, 47-51.</mixed-citation></ref><ref id="scirp.119371-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kasanga, M., Mudenda, S., Siyanga, M., Chileshe, M., Mwiikisa, M.J., Kasanga, M., et al. (2020) Antimicrobial Susceptibility Patterns of Bacteria That Commonly Cause Bacteremia at a Tertiary Hospital in Zambia. Future Microbiology, 15, 1735-1745.  
https://doi.org/10.2217/fmb-2020-0250</mixed-citation></ref><ref id="scirp.119371-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Liu, D., Zhang, L., Zhang, C., Chen, M., Zhang, L., Li, J., et al. (2018) Different Regimens of Penicillin Antibiotics Given to Women Routinely for Preventing Infection after Cesarean Section: A Systematic Review and Meta-Analysis. Medicine (Baltimore), 97, e11889. https://doi.org/10.1097/MD.0000000000011889</mixed-citation></ref><ref id="scirp.119371-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Nazrina, S., Chisty, S. and Maruf, A.A. (2016) Antibiotic Prescribing Pattern in Cesarean Section. Mediscope, 3, 8-15. https://doi.org/10.3329/mediscope.v3i1.29730</mixed-citation></ref><ref id="scirp.119371-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Burke, C. and Allen, R. (2020) Complications of Cesarean Birth: Clinical Recommendations for Prevention and Management. MCN. The American Journal of Maternal/Child Nursing, 45, 92-99. https://doi.org/10.1097/NMC.0000000000000598</mixed-citation></ref><ref id="scirp.119371-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Liu, R., Lin, L. and Wang, D. (2016) Antimicrobial Prophylaxis in Caesarean Section Delivery. Experimental and Therapeutic Medicine, 12, 961-964.  
https://doi.org/10.3892/etm.2016.3350</mixed-citation></ref><ref id="scirp.119371-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Azizi, M., Rajaei, M., Najafian, A., Zare, S., Iranfar, M. and Abbasian, M. (2017) Comparing the Effectiveness of Broad-Spectrum Antibiotic Prophylaxis with Single Agent Antibiotic Prophylaxis to Prevent Post-Cesarean Section Infection. Hormozgan Medical Journal, 20, 287-292.</mixed-citation></ref><ref id="scirp.119371-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Rai, C., Malik, S., Gaikwad, H., Chellani, H. and Kaur, J. (2018) Comparative Evaluation of Antibiotic Prophylaxis in Caesarean Section before Skin Incision and after Cord Clamping. Journal of Medical Science and Clinical Research, 6, 908-913.  
https://doi.org/10.18535/jmscr/v6i6.167</mixed-citation></ref><ref id="scirp.119371-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Novelia, S., Sae Sia, W. and Songwathana, P. (2017) Surgical Site Infection among Women Post-Cesarean Section: An Integrative Review. Nurse Media Journal of Nursing, 7, 46-55. https://doi.org/10.14710/nmjn.v7i1.15127</mixed-citation></ref><ref id="scirp.119371-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Barisic, T., Mandic, V., Tomic, V., Zovko, A. and Novakovic, G. (2017) Antibiotic Prophylaxis for Premature Rupture of Membranes and Perinatal Outcome. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 30, 580-584.  
https://doi.org/10.1080/14767058.2016.1178228</mixed-citation></ref><ref id="scirp.119371-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Zuarez-Easton, S., Zafran, N., Garmi, G. and Salim, R. (2017) Postcesarean Wound Infection: Prevalence, Impact, Prevention, and Management Challenges. International Journal of Women’s Health, 9, 81-88. https://doi.org/10.2147/IJWH.S98876</mixed-citation></ref><ref id="scirp.119371-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Tadesse, B.T., Ashley, E.A., Ongarello, S., Havumaki, J., Wijegoonewardena, M., González, I.J., et al. (2017) Antimicrobial Resistance in Africa: A Systematic Review. BMC Infectious Diseases, 17, Article No. 616.  
https://doi.org/10.1186/s12879-017-2713-1</mixed-citation></ref><ref id="scirp.119371-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Mudenda, S., Witika, B., Sadiq, M., Banda, M., Mfune, R., Daka, V., et al. (2021) Self-Medication and Its Consequences during &amp; after the Coronavirus Disease 2019 (COVID-19) Pandemic: A Global Health Problem. The European Journal of Environment and Public Health, 5, em0066. https://doi.org/10.29333/ejeph/9308</mixed-citation></ref><ref id="scirp.119371-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Jafarzadeh, A., Hadavi, M., Hasanshahi, G., Rezaeian, M., Vazirinejad, R., Aminzadeh, F., et al. (2019) Cesarean or Cesarean Epidemic? Archives of Iranian Medicine, 22, 663-670.</mixed-citation></ref><ref id="scirp.119371-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Gedefaw, G., Demis, A., Alemnew, B., Wondmieneh, A., Getie, A. and Waltengus, F. (2020) Prevalence, Indications, and Outcomes of Caesarean Section Deliveries in Ethiopia: A Systematic Review and Meta-Analysis. Patient Safety in Surgery, 14, Article No. 11.</mixed-citation></ref><ref id="scirp.119371-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Govender, S. (2016) Antibiotic Prophylaxis in A Primary Level Hospital: A Medicines Use Evaluation to Assess Compliance in Caesarean Sections. University of Kwazulu-Natal, Durban. http://hdl.handle.net/10413/15805</mixed-citation></ref><ref id="scirp.119371-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Di Gennaro, F., Marotta, C., Pisani, L., Veronese, N., Pisani, V., Lippolis, V., et al. (2020) Maternal Caesarean Section Infection (MACSI) in Sierra Leone: A Case-Control Study. Epidemiology and Infection, 148, e40.  
https://doi.org/10.1017/S0950268820000370</mixed-citation></ref><ref id="scirp.119371-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Conroy, K., Koenig, A.F., Yu, Y.-H., Courtney, A., Lee, H.J. and Norwitz, E.R. (2012) Infectious Morbidity after Cesarean Delivery: 10 Strategies to Reduce Risk. Reviews in Obstetrics and Gynecology, 5, 69-77.</mixed-citation></ref><ref id="scirp.119371-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2021) WHO Recommendation on Prophylactic Antibiotics for Women Undergoing Caesarean Section. WHO, Geneva.  
https://www.ncbi.nlm.nih.gov/books/NBK571493/</mixed-citation></ref><ref id="scirp.119371-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, M., Sanneving, L., Mahadik, K., Santacatterina, M., Dhaneria, S. and Stalsby, L.C. (2013) Antibiotic Prescribing in Women during and after Delivery in a Non-Teaching, Tertiary Care Hospital in Ujjain, India: A Prospective Cross-Sectional Study. Journal of Pharmaceutical Policy and Practice, 6, Article No. 9.  
https://doi.org/10.1186/2052-3211-6-9</mixed-citation></ref><ref id="scirp.119371-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Shamna, M., Kalaichelvan, V., Marickar, Y. and Deepu, S. (2014) Cesarean Section and Prophylactic Antibiotics. IOSR Journal of Pharmacy and Biological Sciences, 9, 51-54. https://doi.org/10.9790/3008-09235154</mixed-citation></ref><ref id="scirp.119371-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Gondwe, T., Betha, K., Kusneniwar, G.N., Bunker, C.H., Tang, G., Simhan, H., et al. (2019) Maternal Factors Associated with Mode of Delivery in a Population with a High Cesarean Section Rate. Journal of Epidemiology and Global Health, 9, 252-258.  
https://doi.org/10.2991/jegh.k.191017.001</mixed-citation></ref><ref id="scirp.119371-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Dessu, S., Samuel, S., Gebremeskel, F., Basazin, A., Tariku, Z. and Markos, M. (2021) Determinants of Post-Cesarean Section Surgical Site Infection at Public Hospitals in Dire Dawa Administration, Eastern Ethiopia: Case-Control Study. PLOS ONE, 16, e0250174. https://doi.org/10.1371/journal.pone.0250174</mixed-citation></ref><ref id="scirp.119371-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Lijaemiro, H., Berhe Lemlem, S. and Tesfaye Deressa, J. (2020) Incidence of Surgical Site Infection and Factors Associated among Cesarean Deliveries in Selected Government Hospitals in Addis Ababa, Ethiopia, 2019. Obstetrics and Gynecology International, 2020, Article ID: 9714640. https://doi.org/10.1155/2020/9714640</mixed-citation></ref><ref id="scirp.119371-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Gomaa, K., Abdelraheim, A.R., El Gelany, S., Khalifa, E.M., Yousef, A.M. and Hassan, H. (2021) Incidence, Risk Factors and Management of Post-Cesarean Section Surgical Site Infection (SSI) in a Tertiary Hospital in Egypt: A Five-Year Retrospective Study. BMC Pregnancy Childbirth, 21, Article No. 634.  
https://doi.org/10.1186/s12884-021-04054-3</mixed-citation></ref><ref id="scirp.119371-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Shree, R., Park, S.Y., Beigi, R.H., Dunn, S.L. and Krans, E.E. (2016) Surgical Site Infection Following Cesarean Delivery: Patient, Provider, and Procedure-Specific Risk Factors. The American Journal of Perinatology, 33, 157-164.  
https://doi.org/10.1055/s-0035-1563548</mixed-citation></ref><ref id="scirp.119371-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Chu, K., Maine, R. and Trelles, M. (2015) Cesarean Section Surgical Site Infections in Sub-Saharan Africa: A Multi-Country Study from Medecins Sans Frontieres. World Journal of Surgery, 39, 350-355. https://doi.org/10.1007/s00268-014-2840-4</mixed-citation></ref><ref id="scirp.119371-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Mpogoro, F.J., Mshana, S.E., Mirambo, M.M., Kidenya, B.R., Gumodoka, B. and Imirzalioglu, C. (2014) Incidence and Predictors of Surgical Site Infections Following Caesarean Sections at Bugando Medical Centre, Mwanza, Tanzania. Antimicrobial Resistance and Infection Control, 3, Article No. 25.  
https://doi.org/10.1186/2047-2994-3-25</mixed-citation></ref><ref id="scirp.119371-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Wodajo, S., Belayneh, M. and Gebremedhin, S. (2017) Magnitude and Factors Associated with Post-Cesarean Surgical Site Infection at Hawassa University Teaching and Referral Hospital, Southern Ethiopia: A Cross-Sectional Study. Ethiopian Journal of Health Sciences, 27, 283-290. https://doi.org/10.4314/ejhs.v27i3.10</mixed-citation></ref><ref id="scirp.119371-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Morhason-Bello, I.O., Oladokun, A., Adedokun, B.O., Obisesan, K.A., Ojengbede, O.A. and Okuyemi, O.O. (2009) Determinants of Post-Caesarean Wound Infection at the University College Hospital Ibadan Nigeria. Nigerian Journal of Clinical Practice, 12, 1-5.</mixed-citation></ref><ref id="scirp.119371-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Shrestha, S., Shrestha, R., Shrestha, B. and Dongol, A. (2015) Incidence and Risk Factors of Surgical Site Infection Following Cesarean Section at Dhulikhel Hospital. Kathmandu University Medical Journal, 12, 113-116.  
https://doi.org/10.3126/kumj.v12i2.13656</mixed-citation></ref><ref id="scirp.119371-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Jabbar, S., Perveen, S. and Naseer, Q. (2016) Surgical Site Infection (SSI): Frequency and Risk Factors in Post Caesarean Section Cases in a Tertiary Care Hospital. Annals Abbasi Shaheed Hospital &amp; Karachi Medical &amp; Dental College, 21, 233-239.</mixed-citation></ref><ref id="scirp.119371-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Carshon-Marsh, R., Squire, J.S., Kamara, K.N., Sargsyan, A., Delamou, A., Camara, B.S., et al. (2022) Incidence of Surgical Site Infection and Use of Antibiotics among Patients Who Underwent Caesarean Section and Herniorrhaphy at a Regional Referral Hospital, Sierra Leone. International Journal of Environmental Research and Public Health, 19, Article No. 4048. https://doi.org/10.3390/ijerph19074048</mixed-citation></ref><ref id="scirp.119371-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Gentilotti, E., De Nardo, P., Nguhuni, B., Piscini, A., Damian, C., Vairo, F., et al. (2020) Implementing a Combined Infection Prevention and Control with Antimicrobial Stewardship Joint Program to Prevent Caesarean Section Surgical Site Infections and Antimicrobial Resistance: A Tanzanian Tertiary Hospital Experience. Antimicrobial Resistance and Infection Control, 9, Article No. 69.  
https://doi.org/10.1186/s13756-020-00740-7</mixed-citation></ref><ref id="scirp.119371-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Slabuszewska-Józwiak, A., Szymański, J.K., Józwiak, L. and Sarecka-Hujar, B. (2021) A Systematic Review and Meta-Analysis of Wound Complications after a Caesarean Section in Obese Women. Journal of Clinical Medicine, 10, Article No. 675.  
https://doi.org/10.3390/jcm10040675</mixed-citation></ref><ref id="scirp.119371-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Alrammaal, H.H., Batchelor, H.K., Morris, R.K. and Chong, H.P. (2019) Efficacy of Perioperative Cefuroxime as a Prophylactic Antibiotic in Women Requiring Caesarean Section: A Systematic Review. The European Journal of Obstetrics &amp; Gynecology and Reproductive Biology, 242, 71-78.  
https://doi.org/10.1016/j.ejogrb.2019.08.022</mixed-citation></ref><ref id="scirp.119371-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Attah, M.A. (2018) Post-Caesarean Section Infections at the Korle-Bu Teaching Hospital. University of Ghana, Accra. https://doi.org/10.1080/14767058.2017.1401606</mixed-citation></ref><ref id="scirp.119371-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Yisma, E., Smithers, L.G., Lynch, J.W. and Mol, B.W. (2019) Cesarean Section in Ethiopia: Prevalence and Sociodemographic Characteristics. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 32, 1130-1135.</mixed-citation></ref><ref id="scirp.119371-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Dhar, H., Al-Busaidi, I., Rathi, B., Nimre, E.A., Sachdeva, V. and Hamdi, I. (2014) A Study of Post-Caesarean Section Wound Infections in a Regional Referral Hospital, Oman. Sultan Qaboos University Medical Journal, 14, e211-e217.</mixed-citation></ref><ref id="scirp.119371-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Lee, K.-S. and Huang, J.-P. (2019) Short-Term Postop-erative Outcomes between 4% Icodextrin Solution and Hyaluronic Acid-Carboxymethyl Cellulose Membrane during Emergency Cesarean Section. Journal of Clinical Medicine, 8, Article No. 1249.  
https://doi.org/10.3390/jcm8081249</mixed-citation></ref><ref id="scirp.119371-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Kasanga, M., Wu, J., Mukosha, R., Kasanga, M., Siyanga, M., Mudenda, S., et al. (2021) Antimicrobial Resistance Patterns of Bacterial Pathogens Their Distribution in University Teaching Hospitals in Zambia. Future Microbiology, 16, 811-824.  
https://doi.org/10.2217/fmb-2021-0104</mixed-citation></ref><ref id="scirp.119371-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Valent, A.M., DeArmond, C., Houston, J.M., Reddy, S., Masters, H.R., Gold, A., et al. (2017) Effect of Post-Cesarean Delivery Oral Cephalexin and Metronidazole on Surgical Site Infection among Obese Women: A Randomized Clinical Trial. JAMA, 318, 1026-1034. https://doi.org/10.1001/jama.2017.10567</mixed-citation></ref><ref id="scirp.119371-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Menz, B.D., Charani, E., Gordon, D.L., Leather, A.J.M., Moonesinghe, S.R. and Phillips, C.J. (2021) Surgical Antibiotic Prophylaxis in an Era of Antibiotic Resistance: Common Resistant Bacteria and Wider Considerations for Practice. Infection and Drug Resistance, 14, 5235-5252. https://doi.org/10.2147/IDR.S319780</mixed-citation></ref><ref id="scirp.119371-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Iwu-Jaja, C.J., Jaca, A., Jaja, I.F., Jordan, P., Bhengu, P., Iwu, C.D., et al. (2021) Preventing and Managing Antimicrobial Resistance in the African Region: A Scoping Review Protocol. PLOS ONE, 16, e0254737.  
https://doi.org/10.1371/journal.pone.0254737</mixed-citation></ref><ref id="scirp.119371-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Harbarth, S., Balkhy, H.H., Goossens, H., et al. (2015) Antimicrobial Resistance: One World, One Fight! Antimicrobial Resistance &amp; Infection Control, 4, 49.  
https://doi.org/10.1186/s13756-015-0091-2</mixed-citation></ref><ref id="scirp.119371-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Hermsen, E.D., MacGeorge, E.L., Andresen, M.L., et al. (2020) Decreasing the Peril of Antimicrobial Resistance through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship. Advances in Therapy, 37, 918-932. https://doi.org/10.1007/s12325-019-01203-1</mixed-citation></ref><ref id="scirp.119371-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Mudenda, S., Chomba, M., Chabalenge, B., Nang’andu Hikaambo, C., Banda, M., Zulu, A., et al. (2022) Antibiotic Prescribing Patterns in Adult Patients According to the WHO AWaRe Classification: A Multi-Facility Cross-Sectional Study in Primary Healthcare Hospitals in Zambia. Research Square, 1-14.  
https://doi.org/10.21203/rs.3.rs-1879384/v1</mixed-citation></ref><ref id="scirp.119371-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">Hek, K., van Esch, T.E.M., Lambooij, A., Weesie, Y.M. and van Dijk, L. (2020) Guideline Adherence in Antibiotic Prescribing to Patients with Respiratory Diseases in Primary Care: Prevalence and Practice Variation. Antibiotics (Basel), 9, 571.  
https://doi.org/10.3390/antibiotics9090571</mixed-citation></ref><ref id="scirp.119371-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">Niaz, Q., Godman, B., Campbell, S., et al. (2020) Compliance to Prescribing Guidelines among Public Health Care Facilities in Namibia; Findings and Implications. International Journal of Clinical Pharmacy, 42, 1227-1236.  
https://doi.org/10.1007/s11096-020-01056-7</mixed-citation></ref><ref id="scirp.119371-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Wathne, J.S., Harthug, S., Kleppe, L.K.S., et al. (2019) The Association between Adherence to National Antibiotic Guidelines and Mortality, Readmission and Length of Stay in Hospital Inpatients: Results from a Norwegian Multicentre, Observational Cohort Study. Antimicrobial Resistance &amp; Infection Control, 8, 63.  
https://doi.org/10.1186/s13756-019-0515-5</mixed-citation></ref><ref id="scirp.119371-ref59"><label>59</label><mixed-citation publication-type="other" xlink:type="simple">Amaha, N.D., Weldemariam, D.G., Abdu, N., et al. (2019) Prescribing Practices Using WHO Prescribing Indicators and Factors Associated with Antibiotic Prescribing in Six Community Pharmacies in Asmara, Eritrea: A Cross-Sectional Study. Antimicrobial Resistance &amp; Infection Control, 8, 163.  
https://doi.org/10.1186/s13756-019-0620-5</mixed-citation></ref><ref id="scirp.119371-ref60"><label>60</label><mixed-citation publication-type="other" xlink:type="simple">Yin, J., Li, H. and Sun, Q. (2021) Analysis of Antibiotic Consumption by AWaRe Classification in Shandong Province, China, 2012-2019: A Panel Data Analysis. Frontiers in Pharmacology, 12, Article ID: 790817.  
https://doi.org/10.3389/fphar.2021.790817</mixed-citation></ref></ref-list></back></article>